Eric J. Ende, Director at AVADEL PHARMACEUTICALS PLC (AVDL), bought 35,000 shares at $2.16 ($78K) on 2022-05-31, disclosed to the SEC on 2022-06-01.
Open-market purchase of $78k AVDL by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.16 | 15,000 | $32K | 41.6% |
| 2 | $2.27 | 20,000 | $45K | 58.4% |
| Total | $2.22 avg | 35,000 | $78K | 100% |
| Filing → |
| AVDL | BUY | 2022-11-23 | $156K | — | Filing → |
| AVDL | BUY | 2022-05-31 | $37K | — | Filing → |
| AVDL | BUY | 2020-09-18 | $98K | — | Filing → |